UNC Breast Cancer Innovation Program
Developmental Research Program
This program funds new ideas to improve breast cancer prevention, early detection, treatment, and survivorship for people affected by breast cancer.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of North Carolina Chapel Hill NIH-funded |
| Lab location | 1 site (Chapel Hill, United States) |
| Project ID | NIH-11181673 on NIH RePORTER |
What this research studies
From a patient's point of view, this program gives investigators small, competitive awards to try promising new approaches for breast cancer across prevention, population studies, lab-to-clinic work, and clinical care. Proposals are solicited twice yearly across UNC and sister campuses, reviewed by independent scientists together with patient advocates, and selected by the SPORE leadership. The program supports both planned competitive awards and rapid-response opportunities and also helps build shared resources like cellular therapy facilities and large cohort efforts. Its goal is to speed the most promising ideas toward tests and trials that could involve patients.
Who could benefit from this research
Good fit: People with breast cancer, those at high risk for breast cancer, or patients near UNC who are willing to join clinical trials, prevention studies, or donate biospecimens are the most likely to take part in projects funded by this program.
Not a fit: Patients with conditions unrelated to breast cancer or those unable to travel to UNC system sites may not have direct opportunities to participate or benefit from this program's studies.
Why it matters
Potential benefit: If successful, the program could bring new screening methods, prevention strategies, or treatments to patients faster and improve survivorship care.
How similar studies have performed: This Developmental Research Program has supported breast cancer projects since 1992 and has a long track record of generating promising projects and infrastructure investments.
Where this research is happening
Chapel Hill, United States
- Univ of North Carolina Chapel Hill — Chapel Hill, United States (Active)
Researchers
- Principal investigator: Earp, H. Shelton — Univ of North Carolina Chapel Hill
- Study coordinator: Earp, H. Shelton
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.